Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of 24-week Toll-like receptor 9 agonist treatment in HIV type 1+ individuals.
Vibholm LK, Konrad CV, Schleimann MH, Frattari G, Winckelmann A, Klastrup V, Jensen NM, Jensen SS, Schmidt M, Wittig B, Zuwala K, Mack K, Olesen R, Hua S, Lichterfeld M, Østergaard L, Denton PW, Tolstrup M, Søgaard OS. Vibholm LK, et al. Among authors: winckelmann a. AIDS. 2019 Jul 1;33(8):1315-1325. doi: 10.1097/QAD.0000000000002213. AIDS. 2019. PMID: 30932955 Clinical Trial.
Interleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral Reservoir.
Højen JF, Rasmussen TA, Andersen KL, Winckelmann AA, Laursen RR, Gunst JD, Møller HJ, Fujita M, Østergaard L, Søgaard OS, Dinarello CA, Tolstrup M. Højen JF, et al. Among authors: winckelmann aa. Mol Med. 2015 Apr 14;21(1):337-45. doi: 10.2119/molmed.2015.00031. Mol Med. 2015. PMID: 25879630 Free PMC article.
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial.
Rasmussen TA, Tolstrup M, Brinkmann CR, Olesen R, Erikstrup C, Solomon A, Winckelmann A, Palmer S, Dinarello C, Buzon M, Lichterfeld M, Lewin SR, Østergaard L, Søgaard OS. Rasmussen TA, et al. Among authors: winckelmann a. Lancet HIV. 2014 Oct;1(1):e13-21. doi: 10.1016/S2352-3018(14)70014-1. Epub 2014 Sep 15. Lancet HIV. 2014. PMID: 26423811
HIV-1 Reservoirs During Suppressive Therapy.
Barton K, Winckelmann A, Palmer S. Barton K, et al. Among authors: winckelmann a. Trends Microbiol. 2016 May;24(5):345-355. doi: 10.1016/j.tim.2016.01.006. Epub 2016 Feb 12. Trends Microbiol. 2016. PMID: 26875617 Free PMC article. Review.
Broad activation of latent HIV-1 in vivo.
Barton K, Hiener B, Winckelmann A, Rasmussen TA, Shao W, Byth K, Lanfear R, Solomon A, McMahon J, Harrington S, Buzon M, Lichterfeld M, Denton PW, Olesen R, Østergaard L, Tolstrup M, Lewin SR, Søgaard OS, Palmer S. Barton K, et al. Among authors: winckelmann a. Nat Commun. 2016 Sep 8;7:12731. doi: 10.1038/ncomms12731. Nat Commun. 2016. PMID: 27605062 Free PMC article. Clinical Trial.
A5 Peripheral blood cells contribute to HIV-1 viremia induced by romidepsin.
Winckelmann A, Barton K, Hiener B, Shao W, Østergaard L, Rasmussen T, Søgaard O, Tolstrup M, Palmer S. Winckelmann A, et al. Virus Evol. 2017 Mar 5;3(Suppl 1):vew036.004. doi: 10.1093/ve/vew036.004. eCollection 2017 Mar. Virus Evol. 2017. PMID: 28845251 Free PMC article. No abstract available.
23 results